Why the study?
Does an isotope circulation study using 131-labeled diatrizoate detect right to left shunts and assess circulation times in patients with suspected congenital heart disease or mitral valve disease?
Does an isotope circulation study using 131-labeled diatrizoate detect right to left shunts and assess circulation times in patients with suspected congenital heart disease or mitral valve disease?
Answers are grounded in this paper and cite their sources.
Isotope circulation studies using 131-labeled diatrizoate provide a useful, portable method for detecting right-to-left shunts and assessing circulation times without requiring femoral artery puncture.
In the diagnosis of congenital cardiac defects, right to left shunts may be more difficult to detect and accurately localize than left to right shunts. A new procedure developed for detecting shunts consists of injecting a substance (131-labeled sodium and methylglucamine diatrizoate) which serves as a rapidly excreted radioactive tracer. The injection is made into the various chambers of the heart by way of a catheter inserted through a vein, but injection by direct venipuncture also gives useful results. Three radiation counters are placed over the heart, over a peripheral lung field, and over a femoral artery, and the time of appearance of increased radioactivity at these three places is found to give information that cannot be obtained from electrocardiograms, pressure recordings, and angiocardiograms alone. The procedure demonstrated its usefulness in 42 patients suspected of having right to left shunts. A variety of other conditions can also be investigated by this means, and a marked delay (up to 20 seconds, as compared with a normal of 5 seconds) in the appearance of radioactivity in the femoral ortery and leg was among the featues noted in 17 patients with disease of the mitral valve. The apparatus needed in this procedure can be reduced to a compact, portable unit, and the method has obviated the need of puncturing the femoral artery in the detection of intracardiac and extracardiac shunts.
No takes yet. Share an insight, caveat, or question.
Richard H. Greenspan (1959) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: